Peer-reviewed Publications (research articles, published/in press)

  • Zolekar, A., Lin, V.J.T., Mishra, N. M., Ho, Y. Y., Hayatshahi, H. S., Parab, A., Sampat, R., Liao, X., Hoffmann, P., Liu, J., Emmitte, K. A., Wang, Y.-C. (2018) Stress and interferon signalling-mediated apoptosis contributes to pleiotropic anticancer responses induced by targeting NGLY1. Br. J. Cancer, doi: 10.1038/s41416-018-0265-9, in press
  • Lin, V.J.T., Zolekar, A., Shi, Y., Koneru, B., Dimitrijevich, S., Di Pasqua, A.J. and Wang, Y.-C. (2017) Potassium as a pluripotency-associated element identified through inorganic element profiling in human pluripotent stem cells. Sci. Rep., 7 (1):5005, doi: 10.1038/s41598-017-05117-2
  • O’Brien, C.M., Chy, H.S., Zhou, Q., Blumenfeld, S., Lambshead, J.W., Liu, X., Kie, J., Capaldo, B.D., Chung, T.L., Adams, T.E., Phan, T., Bentley, J.D., McKinstry, W.J., Oliva, K., McMurrick, P.J., Wang, Y.-C., Rossello, F.J., Lindeman, G.J., Chen, D., Jarde, T., Clark, A.T., Abud, H.E., Visvader, J.E., Nefzger, C.M., Polo, J.M., Loring, J.F., Laslett, A.L. (2017) New Monoclonal Antibodies to Defined Cell Surface Proteins on Human Pluripotent Stem Cells. Stem Cells, 35 (3):626-640
  • Koneru, B., Shi, Y., Wang, Y.-C., Chavala, S.H., Miller, M.L., Holbert, B., Conson, M., Ni, A. and Di Pasqua A.J. (2015) Tetracycline-containing MCM-41 mesoporous silica nanoparticles for the treatment of Escherichia coli. Molecules, 20 (11), 19690-19698
  • Wang, Y.-C#., Stein, J.W., Lynch, C.L., Tran, H.T., Lee, C.-Y., Coleman, R., Hatch, A., Antontsev, V.G., Chy, H.S., O’Brien, C., Murthy, S.K., Laslett, A.L., Peterson, S.E. and Loring, J.F. (2015) Glycosyltransferase ST6GAL1 contributes to the regulation of pluripotency in human pluripotent stem cells. Sci. Rep., 5:13317 (#Corresponding author)
  • Garitaonandia, I., Boscolo, F.S., Wambua, G., Schultheiz, H., Waltz, S., Wang, Y.-C., Tran, H.T., Leonardo, T., Nazor, K.L., Slavin, I., Lynch, C.L., Li, Y., Coleman, R., Seldeen, J.R., Gallego-Romero, I., Altun, G., Parast, M.M., Loring, J.F. and Laurent, L.C. (2015) Increased risk of genetic and epigenetic instability in human embryonic stem cells associated with specific culture conditions. PLOS One, 10 (2):e0118307
  • Liao, X., Xue, H., Wang, Y.-C., Nazor, K.L., Guo, S., Trivedi, N., Peterson, S.E., Liu, Y., Loring, J.F. and Laurent, L.C. (2013) Matched miRNA and mRNA signatures from an hESC-based in vitro model of pancreatic differentiation reveal novel regulatory interactions. J. Cell Sci., 126:3848-3861
  • Jones, J.C., Sabatini, K., Liao, X., Tran, H.T., Lynch, C.L., Morey, R.E., Boscolo, F.S., Parast, M.M., Liu, Y., Peterson, S.E., Larent, L.C., Loring, J.F. and Wang, Y.-C.# (2013) Melanocytes derived from transgene-free human induced pluripotent stem cells. J. Invest. Dermatol., 133 (8):2104-2108 (#Corresponding author)
  • Ramsköld, D., Luo, S., Wang, Y.-C., Li, R., Deng, Q., Faridani, O.R., Daniels, G.A., Khrebtukova, I., Loring, J.F., Laurent, L.C., Schroth, G.P. and Sandberg, R. (2012) Full-length mRNA-Seq from single cell levels of RNA and individual circulating tumor cells. Nat. Biotechnol., 30 (8):777-782
  • Nazor, K.L., Altun, G., Lynch, C.L., Tran, H.T., Harness, J.V., Slavin, I., Garitaonandia, I., Müller, F.-J., Wang, Y.-C., Boscolo, F.S., Fakunle, E., Dumevska, B., Lee, S., Park, H.S., Olee, T., D’Lima, D.D., Semechkin, R., Parast, M.M., Galat, V., Laslett, A.L., Schmidt, U., Keirstead, H.S., Loring, J. F. and Laurent, L.C. (2012) Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. Cell Stem Cell, 10 (5):620-634
  • Wang, Y.-C., Nakagawa, M., Garitaonandia, I., Slavin, I., Altun, G., Lacharite, R.M., Nazor, K.L., Tran, H.T., Lynch, C.L., Leonardo, T.R., Liu, Y., Peterson, S.E., Laurent, L.C., Yamanaka, S. and Loring, J.F. (2011) Specific lectin biomarkers for isolation of human pluripotent stem cells identified through array-based glycomic analysis. Cell Res., 21 (11):1551-1563 (Highlight Article)
  • Friedrich Ben-Nun, I., Montague, S.C., Houck, M.L., Tran, H.T., Garitaonandia, I., Leonardo, T.R., Wang, Y.-C., Charter, S.J., Laurent, L.C., Ryder, O.A. and Loring, J.F. (2011) Induced pluripotent stem cells from highly endangered species. Nat. Methods, 8, 829–831 (Cover story)
  • Peterson, S.E., Westra, J.W., Rehen, S.K., Young, H., Buschman, D., Paczkowski, C.M., Yung, Y.C., Wang, Y.-C., Lynch, C.L., Tran, H.T., Nickey, K.S., Laurent, L.C., Loring, J.F., Carpenter, M.K. and Chun, J. (2011) Normal human pluripotent stem cell lines exhibit pervasive mosaic aneuploidy. PLoS One, 6 (8):e23018

Peer-reviewed Publications (research articles, prior to 2009)

  • Sargeant, A.M., Rengel, R.C., Kulp, S.K., Klein, R.D., Clinton, S.K., Wang, Y.-C. and Chen, C.S. (2008) OSU-HDAC42, a histone deacetylase inhibitor, blocks prostate tumor progression in the transgenic adenocarcinoma of the mouse prostate model. Cancer Res., 68 (10), 3999-4009
  • Wang, Y.-C., Kulp, S.K., Wang, D., Yang, C.C., Sargeant, A.M., Hung, J.H., Kashida, Y., Yamaguchi, M., Chang, G.D. and Chen, C.S. (2008) Targeting endoplasmic reticulum stress and Akt with OSU-03012 and gefitinib or erlotinib to overcome resistance to epidermal growth factor receptor Inhibitors. Cancer Res., 68 (8), 2820-2830
  • Yang, J., Wei, S., Wang, D.S., Wang, Y.-C., Kulp, S.K., and Chen, C.S. (2008) Pharmacological exploitation of the proliferator-activated receptor g agonist ciglitazone to develop a novel class of androgen receptor-ablative agents. J. Med. Chem., 51(7), 2100-2107
  • Hung, J.H., Lu, Y.S., Wang, Y.-C., Ma, Y.H., Wang, D., Kulp, S.K., Muthusamy, N., Byrd, J.C., Cheng, A.L. and Chen, C.S. (2008) FTY720 induces apoptosis in hepatocellular carcinoma cells in part through activation of reactive oxygen species-protein kinase C delta signaling. Cancer Res., 68(4), 1204-1212
  • Shih, C.M., Chen, K., Wang, Y.-C., Lee, P.J. and Wang, Y.C. (2007) Elevated p53 and p21waf1 mRNA expression in blood lymphocytes from lung cancer patients with chemoresistance. Cancer Detect. Prev., 31(5), 366-370
  • Porchia, L.M., Guerra, M., Wang, Y.-C., Zhang, Y. Espinosa, A.V., Shinohara, M., Kulp, S.K., Kirschner, L.S., Saji, M., Chen, C.S. and Ringel, M.D. (2007) 2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl} acetamide (OSU-03012), a celecoxib derivative, directly targets p21-activated kinase. Mol. Pharmacol., 72(5):1124-1131 (Cover story)
  • Lu, Y.S., Kashida, Y., Kulp, S.K., Wang, Y.-C., Hung, J.H., Tang, M., Lin, Z.Z., Chen, T.J., Cheng, A.L. and Chen, C.S. (2007) Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma. Hepatology., 46(4), 1119-1130
  • Wei, S., Lin, L.F., Yang, C.C., Wang, Y.-C., Chang, G.D., Chen, H. and Chen, C.S. (2007) Thiazolidinediones modulate the expression of beta-catenin and other cell-cycle regulatory proteins by targeting the F-box proteins of Skp1-Cul1-F-box protein E3 ubiquitin ligase independently of peroxisome proliferator-activated receptor gamma. Mol. Pharmacol., 72(3), 725-733
  • Chen, C.S., Wang, Y.-C., Yang, H.C., Huang, P.H., Kulp, S.K., Yang, C.C., Lu, Y.S., Matsuyama, S., Chen, C.Y. and Chen C.S. (2007) Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation. Cancer Res., 67(11):5318-5327
  • Yang, C.C., Wang, Y.-C., Shuo, Wei, Lin, L.F., Chen, C.S., Lee, C.C., Lin, C.C. and Chen, C.S. (2007) Peroxisome proliferator-activated receptor γ-independent suppression of androgen receptor expression by troglitazone. Mechanism and pharmacological exploitation. Cancer Res., 67(7), 3229-3238
  • Tseng, P.H., Wang, Y.-C., Weng, S.C., Weng, J.R., Chen, C.S., Brueggemeier, R.W., Shapiro, C.L., Chen, C.Y., Dunn, S.E., Pollak, M., Chen, C.S. (2006) Overcoming trastuzumab resistance in HER2-overexpressing breast cancer cells by using a novel celecoxib-derived phosphoinositide-dependent kinase-1 inhibitor. Mol. Pharmacol., 70(5), 1534-1541
  • Wang, Y.-C., Chuang, R.H. and Tung, L.C. (2004) Comparison of the cytotoxicity induced by different exposure of sodium arsenite in two fish cell lines. Aquat. Toxicol., 69(1), 67-79
  • Wang, Y.-C., Lee, P.J., Shih, C.M., Chen, H.Y., Lee, C.C., Chang, Y.Y., Hsu, Y.T., Liang, Y.J., Wang, L.Y., Han, W.H. and Wang, Y.C. (2003) Damage formation and repair efficiency in the p53 gene of cell lines and blood lymphocytes assayed by multiplex long quantitative polymerase chain reaction. Anal. Biochem., 319(2), 206-215
  • Shih, C.M., Kuo, Y.Y., Wang, Y.-C., Jian, S.L., Hsu, Y.T., Wu, H.Y., Guo, M.W. and Wang, Y.C. (2002) Association of L-myc polymorphism with lung cancer susceptibility and prognosis in relation to age-selected controls and stratified cases. Lung cancer, 36(2), 125-32

Peer-reviewed Publications (review articles, published/in press)

  • Mull, A.N., Zolekar, A. and Wang, Y.-C.# (2015) Understanding Melanocyte Stem Cells for Disease Modeling and Regenerative Medicine Applications. Int. J. Mol. Sci.,16 (12):30458-30469
  • Lin, V., Wang, Y.-C.#. and Watson D#. (2015) Perichondrial progenitor cells in cartilage tissue enginerring and regenerative medicine. Current Tissue Engineering, 4 (2):122-127 (#Corresponding author)
  • Wang, Y.-C.#, Lin, V., Loring, J.F. and Peterson, S.E. (2015) The “sweet” spot of cellular pluripotency: protein glycosylation in human pluripotent stem cells and its applications in regenerative medicine. Expert Opin. Biol. Ther., 15 (5):679-687 (Invited article, #Corresponding author)
  • Wang, Y.-C.#, Peterson, S.E. and Loring, J.F. (2014) Protein post-translational modifications and regulation of cellular pluripotency in human stem cells. Cell Res., 24(2):143-160 (Invited article, Grant-aided Open Access Article selected by Cell Res. and China Association for Science and Technology; #Corresponding author)

Books and Chapters

  • Carmel O’Brien, Jack Lambshead, Hun Chy, Qi Zhou, Yu-Chieh Wang and Andrew L. Laslett. (2012) Analysis and purification techniques for human pluripotent stem cells. In Jeanne Loring and Suzanne Peterson, Human Stem Cell Manual (2nd ed., 223-247). San Diego: Elsevier